Announcements Trials

Browse Landscape

Sponsor

Interventions

pembrolizumab 22 Nivolumab 14 enfortumab vedotin 12 Gemcitabine 11 Specimen Handling 10 Magnetic Resonance Spectroscopy 10 Cisplatin 8 Carboplatin 8 avelumab 7 sacituzumab govitecan 6 Docetaxel 6 atezolizumab 5 Ipilimumab 5 durvalumab 4 Paclitaxel 4 cabozantinib 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 tislelizumab 2 relatlimab 2 erdafitinib 2 disitamab vedotin 2 Radiosurgery 2 Platinum 2 Oxaliplatin 2 Fluorouracil 2 Disulfides 2 Cyclophosphamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × naptumomab estafenatox × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡